Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.6455-6457 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6457 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 6455 |
| container_title | Blood |
| container_volume | 140 |
| creator | Carrancio, Soraya Chou, Wen-Chi Risueño, Alberto Guarinos, Carla Lopez, Gonzalo Michot, Jean-Marie Nastoupil, Loretta J. Chavez, Julio Carpio, Cecilia Ferrari, Silvia Feldman, Tatyana A. Morillo Giles, Daniel Pinto, Antonio Greenawalt, Danielle Pierce, Daniel W. Pourdehnad, Michael |
| description | |
| doi_str_mv | 10.1182/blood-2022-159585 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_159585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122044299</els_id><sourcerecordid>S0006497122044299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1375-294bf733e717402190031830194aebaec1201dc98c79ba3df9704ccced3a65863</originalsourceid><addsrcrecordid>eNp9kc-O0zAQxiMEEmXhAbjNsT1k6z9JE4tTyRa6UraLouUcufakNSRxZbuL-pi8ES7Z855Gmpnfp2_mS5LPlNxSWrLlvrdWp4wwltJc5GX-JpnRnJUpIYy8TWaEkFWaiYK-Tz54_4sQmnGWz5K_a--tMjIYO4Lt4H4YziPC3WWUg1Ee5KjhyaEMA44BHs9B2QHBjPAjIrHlYX4KfgF_TDhCg708edTLBjsnVbDuAjs7plurD78jU1-G09EOEubNsoHdtl5M2qgnPhwx7j9jDxU6jCeNMK-ar7sFbDjU5iA9woPV515G6Tja1A_2bgHrw9VbVaVCsJJ9TN51svf46aXeJD-_bZ6qbVo_fr-v1nWqKC_ylIls3xWcY0GLjDAqCOG05ISKTOJeoqKMUK1EqQqxl1x3oiCZUgo1l6u8XPGbhE66ylnvHXbtyZlBuktLSXvNpP2fSXvNpJ0yicyXicFo7Nmga72KX4yixqEKrbbmFfofvlqTZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Carrancio, Soraya ; Chou, Wen-Chi ; Risueño, Alberto ; Guarinos, Carla ; Lopez, Gonzalo ; Michot, Jean-Marie ; Nastoupil, Loretta J. ; Chavez, Julio ; Carpio, Cecilia ; Ferrari, Silvia ; Feldman, Tatyana A. ; Morillo Giles, Daniel ; Pinto, Antonio ; Greenawalt, Danielle ; Pierce, Daniel W. ; Pourdehnad, Michael</creator><creatorcontrib>Carrancio, Soraya ; Chou, Wen-Chi ; Risueño, Alberto ; Guarinos, Carla ; Lopez, Gonzalo ; Michot, Jean-Marie ; Nastoupil, Loretta J. ; Chavez, Julio ; Carpio, Cecilia ; Ferrari, Silvia ; Feldman, Tatyana A. ; Morillo Giles, Daniel ; Pinto, Antonio ; Greenawalt, Danielle ; Pierce, Daniel W. ; Pourdehnad, Michael</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-159585</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.6455-6457</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Carrancio, Soraya</creatorcontrib><creatorcontrib>Chou, Wen-Chi</creatorcontrib><creatorcontrib>Risueño, Alberto</creatorcontrib><creatorcontrib>Guarinos, Carla</creatorcontrib><creatorcontrib>Lopez, Gonzalo</creatorcontrib><creatorcontrib>Michot, Jean-Marie</creatorcontrib><creatorcontrib>Nastoupil, Loretta J.</creatorcontrib><creatorcontrib>Chavez, Julio</creatorcontrib><creatorcontrib>Carpio, Cecilia</creatorcontrib><creatorcontrib>Ferrari, Silvia</creatorcontrib><creatorcontrib>Feldman, Tatyana A.</creatorcontrib><creatorcontrib>Morillo Giles, Daniel</creatorcontrib><creatorcontrib>Pinto, Antonio</creatorcontrib><creatorcontrib>Greenawalt, Danielle</creatorcontrib><creatorcontrib>Pierce, Daniel W.</creatorcontrib><creatorcontrib>Pourdehnad, Michael</creatorcontrib><title>Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc-O0zAQxiMEEmXhAbjNsT1k6z9JE4tTyRa6UraLouUcufakNSRxZbuL-pi8ES7Z855Gmpnfp2_mS5LPlNxSWrLlvrdWp4wwltJc5GX-JpnRnJUpIYy8TWaEkFWaiYK-Tz54_4sQmnGWz5K_a--tMjIYO4Lt4H4YziPC3WWUg1Ee5KjhyaEMA44BHs9B2QHBjPAjIrHlYX4KfgF_TDhCg708edTLBjsnVbDuAjs7plurD78jU1-G09EOEubNsoHdtl5M2qgnPhwx7j9jDxU6jCeNMK-ar7sFbDjU5iA9woPV515G6Tja1A_2bgHrw9VbVaVCsJJ9TN51svf46aXeJD-_bZ6qbVo_fr-v1nWqKC_ylIls3xWcY0GLjDAqCOG05ISKTOJeoqKMUK1EqQqxl1x3oiCZUgo1l6u8XPGbhE66ylnvHXbtyZlBuktLSXvNpP2fSXvNpJ0yicyXicFo7Nmga72KX4yixqEKrbbmFfofvlqTZQ</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Carrancio, Soraya</creator><creator>Chou, Wen-Chi</creator><creator>Risueño, Alberto</creator><creator>Guarinos, Carla</creator><creator>Lopez, Gonzalo</creator><creator>Michot, Jean-Marie</creator><creator>Nastoupil, Loretta J.</creator><creator>Chavez, Julio</creator><creator>Carpio, Cecilia</creator><creator>Ferrari, Silvia</creator><creator>Feldman, Tatyana A.</creator><creator>Morillo Giles, Daniel</creator><creator>Pinto, Antonio</creator><creator>Greenawalt, Danielle</creator><creator>Pierce, Daniel W.</creator><creator>Pourdehnad, Michael</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282</title><author>Carrancio, Soraya ; Chou, Wen-Chi ; Risueño, Alberto ; Guarinos, Carla ; Lopez, Gonzalo ; Michot, Jean-Marie ; Nastoupil, Loretta J. ; Chavez, Julio ; Carpio, Cecilia ; Ferrari, Silvia ; Feldman, Tatyana A. ; Morillo Giles, Daniel ; Pinto, Antonio ; Greenawalt, Danielle ; Pierce, Daniel W. ; Pourdehnad, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1375-294bf733e717402190031830194aebaec1201dc98c79ba3df9704ccced3a65863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carrancio, Soraya</creatorcontrib><creatorcontrib>Chou, Wen-Chi</creatorcontrib><creatorcontrib>Risueño, Alberto</creatorcontrib><creatorcontrib>Guarinos, Carla</creatorcontrib><creatorcontrib>Lopez, Gonzalo</creatorcontrib><creatorcontrib>Michot, Jean-Marie</creatorcontrib><creatorcontrib>Nastoupil, Loretta J.</creatorcontrib><creatorcontrib>Chavez, Julio</creatorcontrib><creatorcontrib>Carpio, Cecilia</creatorcontrib><creatorcontrib>Ferrari, Silvia</creatorcontrib><creatorcontrib>Feldman, Tatyana A.</creatorcontrib><creatorcontrib>Morillo Giles, Daniel</creatorcontrib><creatorcontrib>Pinto, Antonio</creatorcontrib><creatorcontrib>Greenawalt, Danielle</creatorcontrib><creatorcontrib>Pierce, Daniel W.</creatorcontrib><creatorcontrib>Pourdehnad, Michael</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carrancio, Soraya</au><au>Chou, Wen-Chi</au><au>Risueño, Alberto</au><au>Guarinos, Carla</au><au>Lopez, Gonzalo</au><au>Michot, Jean-Marie</au><au>Nastoupil, Loretta J.</au><au>Chavez, Julio</au><au>Carpio, Cecilia</au><au>Ferrari, Silvia</au><au>Feldman, Tatyana A.</au><au>Morillo Giles, Daniel</au><au>Pinto, Antonio</au><au>Greenawalt, Danielle</au><au>Pierce, Daniel W.</au><au>Pourdehnad, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>6455</spage><epage>6457</epage><pages>6455-6457</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-159585</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.6455-6457 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_159585 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Immune%20Dynamics%20and%20Treatment%20Outcome%20in%20Patients%20(pts)%20with%20Relapsed/Refractory%20Non-Hodgkin%20Lymphoma%20(R/R%20NHL)%20Treated%20with%20the%20Novel%20Cereblon%20(CRBN)%20E3%20Ligase%20Modulator%20(CELMoD)%20Agent%20CC-99282&rft.jtitle=Blood&rft.au=Carrancio,%20Soraya&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=6455&rft.epage=6457&rft.pages=6455-6457&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-159585&rft_dat=%3Celsevier_cross%3ES0006497122044299%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122044299&rfr_iscdi=true |